It has also been shown to enhance α-synuclein clearance, reduce amyloid uptake, and improve cognition and memory in PD and AD models (Qiao et al., 2020; Marizzoni et al., 2020; Wang et al., 2022). The gene discussed is SNCA; the disease is Parkinson disease.